Hepcidin: A useful marker in chronic obstructive pulmonary disease

PURPOSE: This study was designed to evaluate the levels of hepcidin in the serum of patients with chronic obstructive pulmonary disease (COPD). METHODS: In the study, 74 male patients (ages 45-75) in a stable period for COPD were grouped as Group I: Mild COPD (n:25), Group II: Moderate COPD (n:24), and Group III: Severe COPD (n:25). Healthy non-smoker males were included in Group IV (n:35) as a control group. The differences of hepcidin level among all the groups were examined. Also, in the patient groups with COPD, hepcidin level was compared with age, body mass index, cigarette (package/year), blood parameters (iron, total iron binding capacity, ferritin, hemoglobin, hematocrit [hct]), respiratory function tests, and arterial blood gas results. RESULTS: Although there was no difference between the healthy control group and the mild COPD patient group (P=0.781) in terms of hepcidin level, there was a difference between the moderate (P=0.004) and the severe COPD patient groups (P=0.002). The hepcidin level of the control group was found to be higher than the moderate and severe COPD patient groups. In the severe COPD patients, hepcidin level increased with the increase in serum iron (P=0.000), hct (P=0.009), ferritin levels (P=0.012), and arterial oxygen saturation (SaO2, P=0.000). CONCLUSION: The serum hepcidin level that is decreased in severe COPD brings into mind that it may play a role in the mechanism to prevent hypoxemia. The results suggest that serum hepcidin level may be a useful marker in COPD. Larger prospective studies are needed to confirm our findings between hepcidin and COPD.

[1]  Jennifer L. Turi,et al.  Hepcidin expression in human airway epithelial cells is regulated by interferon-γ , 2011, Respiratory research.

[2]  D. Swinkels,et al.  Effect of body mass index reduction on serum hepcidin levels and iron status in obese children , 2010, International Journal of Obesity.

[3]  G. Fantuzzi,et al.  Elevated Systemic Hepcidin and Iron Depletion in Obese Premenopausal Females , 2010, Obesity.

[4]  Kyoung-Woon Kim,et al.  Serum Pro-hepcidin Could Reflect Disease Activity in Patients with Rheumatoid Arthritis , 2010, Journal of Korean medical science.

[5]  M. Zimmermann,et al.  Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children , 2009, International Journal of Obesity.

[6]  T. Ganz,et al.  Involvement of Hepcidin in the Anemia of Multiple Myeloma , 2008, Clinical Cancer Research.

[7]  A. Işık,et al.  Serum Pro-hepcidin Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus , 2008, Inflammation.

[8]  D. Swinkels,et al.  Hepcidin: from discovery to differential diagnosis , 2008, Haematologica.

[9]  William C. Florence,et al.  Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis , 2007, Journal of leukocyte biology.

[10]  H. Umehara,et al.  Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. , 2006, Blood.

[11]  A. Agustí.  Thomas a. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. , 2006, Proceedings of the American Thoracic Society.

[12]  T. Ganz,et al.  Regulation of iron acquisition and iron distribution in mammals. , 2006, Biochimica et biophysica acta.

[13]  A. Agustí,et al.  Chronic obstructive pulmonary disease : A systemic disease , 2006 .

[14]  D. Swinkels,et al.  Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. , 2005, Blood.

[15]  Tomas Ganz,et al.  Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages. , 2005, Best practice & research. Clinical haematology.

[16]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[17]  V. Lauta,et al.  A review of the cytokine network in multiple myeloma , 2003, Cancer.

[18]  Elizabeta Nemeth,et al.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. , 2003, Blood.

[19]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[20]  J. Vestbo,et al.  Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study , 2002, European Respiratory Journal.

[21]  A. Schols,et al.  Systemic effects in COPD. , 2002, Chest.

[22]  A. Ionescu,et al.  Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[23]  Christina H. Park,et al.  Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.

[24]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[25]  H. Yamamoto,et al.  Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary disease. , 1983, The New England journal of medicine.